NDAORALTABLET
Approved
Dec 2017
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
Drug data last refreshed 21h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SEGLUROMET is a fixed-dose combination of ertugliflozin (an SGLT2 inhibitor) and metformin hydrochloride (a biguanide) indicated for type 2 diabetes mellitus. The combination leverages dual mechanisms to improve glycemic control: metformin reduces hepatic glucose production and improves insulin sensitivity, while ertugliflozin promotes urinary glucose excretion. Approved in December 2017, it addresses patients requiring dual therapy who benefit from simplified dosing.
$0.001BPart D
PeakStable
5.1 years to LOEProduct is at peak lifecycle maturity with minimal commercial growth; team size likely stable and focused on defensive market share strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SEGLUROMET offers exposure to a stable, post-launch oral diabetes franchise within Merck's portfolio, with emphasis on commercial execution and market defense rather than innovation. Career progression is likely incremental, with roles centered on managed care negotiations, field force effectiveness, and competitive positioning ahead of 2030-2031 LOE.
Brand Manager
Worked on SEGLUROMET at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.